880361-95-5 Usage
Chemical class
Diazepane derivative
Explanation
It belongs to a class of compounds that have a diazepane ring in their structure.
Explanation
It contains a diazepane ring and a methyl-pyridin-2-yl group, making it a heterocyclic compound.
Explanation
The compound's structure consists of a diazepane ring fused with a methyl-pyridin-2-yl group.
Explanation
Diazepane derivatives, in general, have been studied for their potential biological activities, particularly in the central nervous system.
Explanation
The specific properties and potential uses of 1-(6-methyl-pyridin-2-yl)-[1,4]diazepane have not been extensively documented.
Explanation
It represents a potentially important compound for further research and development in the field of medicinal chemistry and drug discovery.
Explanation
Due to limited documentation, the specific applications of 1-(6-methyl-pyridin-2-yl)-[1,4]diazepane are not well-known.
Explanation
The material does not include information on the synthesis of 1-(6-methyl-pyridin-2-yl)-[1,4]diazepane.
Heterocyclic compound
Yes
Structure
Contains a diazepane ring and a methyl-pyridin-2-yl group
Potential biological activities
Therapeutic applications in the central nervous system
Extensive documentation
Limited
Research and development
Potentially important compound
Applications
Unknown at this time
Safety and toxicity
Not documented
Synthesis
Not provided
Check Digit Verification of cas no
The CAS Registry Mumber 880361-95-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,0,3,6 and 1 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 880361-95:
(8*8)+(7*8)+(6*0)+(5*3)+(4*6)+(3*1)+(2*9)+(1*5)=185
185 % 10 = 5
So 880361-95-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H17N3/c1-10-4-2-5-11(13-10)14-8-3-6-12-7-9-14/h2,4-5,12H,3,6-9H2,1H3
880361-95-5Relevant articles and documents
PHENYL mTORC INHIBITORS AND USES THEREOF
-
, (2018/05/27)
The present invention provides compounds, compositions thereof, and methods of using the same.
CXCR4 Receptor Antagonists
-
Paragraph 0377; 0378, (2013/11/06)
Disclosed are compounds that are antagonists of the CXCR4 receptor.